Results 141 to 150 of about 30,886 (233)

Epigenetic Regulation of NKT-Cell-Related Gene Signatures and Prognostic Implications in Oropharyngeal Squamous Cell Carcinoma. [PDF]

Cancers (Basel)
Minarik L, Khoueiry R, Leskur M, Cahais V, Herceg Z, Glavina Durdov M, Benzon B.   +6 more
europepmc   +1 more source

Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines. [PDF]

Vaccines (Basel), 2021
Albutti A, Longet S, McEntee CP, Quinn S, Liddicoat A, Rîmniceanu C, Lycke N, Lynch L, Cardell S, Lavelle EC.   +9 more
europepmc   +1 more source

A Phase I/II Study of Ibrutinib Plus Trastuzumab in HER2‐Positive Metastatic Breast Cancer

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Ibrutinib has demonstrated inhibition of ErbB/HER tyrosine kinases in preclinical models. This Phase I/II study investigated the safety, efficacy, and immunomodulatory effects of ibrutinib in combination with trastuzumab in patients with HER2‐positive metastatic breast cancer (MBC) whose disease had progressed on ado‐trastuzumab emtansine ...
Joyce O'Shaughnessy, Andrea Glidden, Tracy Locke, Amy Scales, Elizabeth Gatewood, Jean‐Philippe Blanck, Jessica Castaneda‐Gill, Sharlin Patel, Yolanda D. Mahnke, Xuan Wang, Page Blas   +10 more
wiley   +1 more source

Engineering CAR T NK and NKT cell therapies to target cancer stem cells and overcome stem like resistance. [PDF]

Discov Oncol
Allela OQB, Shareef A, Jyothi SR, Nayak PP, Janney JB, Singh G, Chauhan AS, Oripov F, Sameer HN, Yaseen A, Salih RM, Adil M.   +11 more
europepmc   +1 more source

Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression. [PDF]

Cancers (Basel), 2021
Proctor M, Gonzalez Cruz JL, Daignault-Mill SM, Veitch M, Zeng B, Ehmann A, Sabdia M, Snell C, Keane C, Dolcetti R, Haass NK, Wells JW, Gabrielli B.   +12 more
europepmc   +1 more source

Editorial: NKT Cells in Cancer Immunotherapy [PDF]

Frontiers in Immunology, 2020
Tonya J. Webb, Weiming Yuan, Everett Meyer, Paolo Dellabona   +3 more
openaire   +3 more sources

The Postprandial Chronobiome in Interorgan Glucose Homeostasis

Comprehensive Physiology, Volume 16, Issue 4, August 2026.
The postprandial chronobiome framework proposes that meal‐timed oscillations in microbial communities and metabolites may interact with host tissue clocks to shape glucose handling. The liver is the best‐supported temporal interpreter, while phase‐aware human studies are needed to establish causal interorgan effects.
Josko Bozic, Roko Santic, Marko Kumric
wiley   +1 more source

STAT3 regulates NK and NKT cell differentiation through C-X3-C motif chemokine receptor 1  (CX3CR1) in hyper-IgE syndrome. [PDF]

Mol Biomed
Liu J, Yang J, Tang J, Tang H, Dai X, Jin P, Huang Y, Li Z, Zhang Z, Guo X, Bitzan M, Yin X, Liu C.   +12 more
europepmc   +1 more source

CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy. [PDF]

Cancer Immunol Immunother, 2021
Hara A, Koyama-Nasu R, Takami M, Toyoda T, Aoki T, Ihara F, Kobayashi M, Hirono S, Matsutani T, Nakayama T, Iwadate Y, Motohashi S.   +11 more
europepmc   +1 more source

Analysis of the Clinical Application Value of Immune Function Markers and Cytokines in the Recurrent Aphthous Ulcer

Clinical and Experimental Dental Research, Volume 12, Issue 4, August 2026.
ABSTRACT Background This study aimed to analyze the alterations in cellular and humoral immune functions, alongside cytokine profiles, in patients with recurrent aphthous ulcer (RAU) compared to those with other oral mucosal diseases and healthy controls (HC), and to investigate their clinical significance.
Yiwen Chen, Ting Meng, Lahong Zhang, Qiang Ke   +3 more
wiley   +1 more source